Imperial College London partners with NHS Trust to make PPE
More than 6,000 visors have already been delivered to Charing Cross Hospital
7th May 2020
Latest news
Rebiotix, Ferring's microbiome-based therapy RBX2660 shows promise
RBX2660 may bring an innovative therapeutic option to patients suffering from C. diff
6th May 2020
Speedy US approval for Novartis' Tabrecta
The approval gives NSCLC patients whose tumours carry the MET exon 14 skipping mutation a new treatment option
6th May 2020
Aberdeen Uni proceeds with COVID-19 mass screening research
The Scottish government has given funds £101,903 to support the project
6th May 2020
US regulators permit AbbVie/Allergan merger
The closing of the acquisition remains subject to other customary closing conditions
6th May 2020
NICE publishes rapid COVID-19 guideline for acute kidney injury
The guideline is designed to help healthcare professionals who are not kidney specialists to prevent, detect and manage AKI in hospitalised patients with suspected or confirmed COVID-19
6th May 2020
US OK's AZ' Farxiga for heart failure with reduced ejection fraction
Farxiga is the first sodium glucose co-transporter 2 inhibitor cleared by the FDA to treat heart failure with reduced ejection fraction
6th May 2020
ICR welcomes new advanced prostate cancer treatment guideline
NHS England has expanded access to targeted hormone therapies for advanced prostate cancer
6th May 2020
Menarini to buy Stemline for up to $677 million
The move will establish Menarini's presence in the US biopharma market
5th May 2020
Newron drops development of sarizotan in Rett syndrome
The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints
5th May 2020
Sanofi/Regeneron's Libtayo shows benefit in BCC
BCC marks the second non-melanoma skin cancer for which Libtayo has demonstrated first-in-class data, the firms note
5th May 2020
JEDI launches billion molecules agains COVID19 challenge
The Billion Molecules against Covid19 Grand Challenge aims to screen billions of molecules with blocking interactions on SARS-CoV-2
5th May 2020
Crescendo links with CRUK to progress cancer therapy
The charity's Centre for Drug Development will sponsor and fund a future Phase I clinical trial for CB213
5th May 2020
Gov't begins roll out of track and trace COVID-19 app
The programme is expected to roll out nationally mid-May
5th May 2020
Inaugural Patient Partnership Index 2020 launches
The Index is a first-of-its-kind opportunity for pharma companies to showcase, benchmark and measure the quality of their partnership working with patient communities
4th May 2020
